I-BET151 significantly delays the development of AML phenotypes, such as splenomegaly, increases the white blood cell count, and decreases the red blood cell count in an AML mouse model induced by two mutations, DNMT3A R882H and RAS G12D (39). This evidence concerns the gene DNMT3A and acute myeloid leukemia.